Biora Therapeutics Inc. (BIOR) Fundamentals

Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology. Geographically, it operates only in the United States.
SHARE INFORMATION
Market Cap$ 42,033,116
Shares Outstanding9,098,077
Float6,583,703
Percent Float72.36%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 25,606,000
Latest Fiscal EPS$ -67.25
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions87
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months321,716
Institutional Holdings Percent29.6%
Institutional Sold Previous 3 Months1,051,611
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months33,109,666
Insider Holdings Percent9.1
Insider Sold Previous 3 Months8,281,960
Insider Shares Owned20,398,388
TRADING INFO
52 Week High$ 52.75
52 Week Low$ 1.95
52 Week High Change$ -88.00
21 Day Moving Average$ 3.8892
21 Day Extended Moving Average$ 4.2449
50 Day Moving Average$ 4.7753
50 Day Extended Moving Average$ 5.3454
200 Day Moving Average$ 14.1675
200 Day Extended Moving Average$ 16.5172
10 Day Average Volume7,788,896
20 Day Average Volume6,788,527
30 Day Average Volume4,547,041
50 Day Average Volume2,753,985
Alpha-0.080395
Beta1.0564
Standard Deviation0.387524
R20.022699
7 Day Price Change$ -0.04
7 Day Percent Change-0.86%
21 Day Price Change$ 2.28
21 Day Percent Change97.44%
30 Day Price Change$ 0.645
30 Day Percent Change16.23%
Month to Date Price Change$ 1.33
Month to Date Percent Change40.32%
Quarter to Date Price Change$ 1.33
Quarter to Date Percent Change40.32%
180 Day Price Change$ -12.82
180 Day Percent Change-73.51%
200 Day Price Change$ -12.63
200 Day Percent Change-73.22%
Year to Date Price Change$ 1.33
Year to Date Percent Change40.32%

Biora Therapeutics Inc. (BIOR) Key Ratios

PROFITABILITY
EBIT Margin-8,304.0%
EBITDA Margin-8,149.4%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin100.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 291,000
Revenue Per Share$ 0.032
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-0.40
Total Debt To Equity0.00
Int Coverage-21.20
Current Ratio1.70
Leverage Ratio-0.80
Quick Ratio1.40
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-0.30
Enterprise Value$ 132,388,519
Price to Sales144.4437
Price to Free Cash-0.70
PE High Last 5 Years0.00
Price To Book0.00
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book-0.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.40
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-161.40
Return on Equity94.85
Return on Capital0.00

Biora Therapeutics Inc. (BIOR) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorKPMG LLP
CEOAditya P. Mohanty
Emplyoees124
Last AuditUE
CIK0001580063
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address4330 La Jolla Village Drive
Suite 300
San Diego, CA 92122
Websitehttps://www.bioratherapeutics.com
Facsimile+1 248 848-1623
Telephone+1 855 293-2639
Email-


Your Recent History
NASDAQ
BIOR
Biora Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.